<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19015331</PMID><DateCompleted><Year>2009</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-6596</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>2</Issue><PubDate><Year>2009</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Antimicrobial agents and chemotherapy</Title><ISOAbbreviation>Antimicrob Agents Chemother</ISOAbbreviation></Journal><ArticleTitle>Real-time monitoring of human enterovirus (HEV)-infected cells and anti-HEV 3C protease potency by fluorescence resonance energy transfer.</ArticleTitle><Pagination><StartPage>748</StartPage><EndPage>755</EndPage><MedlinePgn>748-55</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/AAC.00841-08</ELocationID><Abstract><AbstractText>A real-time assay system that allows monitoring of intracellular human enterovirus (HEV) protease activity was established using the principle of fluorescence resonance energy transfer (FRET). It was accomplished by engineering cells to constitutively express a genetically encoded FRET probe. The FRET-based probe was designed to contain an enterovirus 71 3C protease (3C(pro)) cleavage motif flanked by the FRET pair composed of green fluorescent protein 2 and red fluorescent protein 2 (DsRed2). Efficient FRET from the stable line was detected in a real-time manner by fluorescence microscopy, and the disruption of FRET was readily monitored upon HEV infection. The level of the repressed FRET was proportional to the input virus titer and the infection duration as measured by the fluorometric method. The FRET biosensor cell line was also responsive to other related HEV serotypes, but not to the phylogenetically distant herpes simplex virus, which was confirmed by Western blot analysis. The FRET biosensor was then utilized to develop a format for the determination of antiviral susceptibility, as the reduced FRET appeared to reflect viral replication. Evaluations of the FRET biosensor system with representative HEV serotypes demonstrated that their susceptibilities to a 3C(pro) inhibitor, rupintrivir, were all accurately determined. In summary, this novel FRET-based system is a means for rapid detection, quantification, and drug susceptibility testing for HEVs, with potential for the development of a high-throughput screening assay.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Meng-Tian</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Biotechnology and Laboratory Science in Medicine, National Yang-Ming University, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yun-Hsiang</ForeName><Initials>YH</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yu-Ning</ForeName><Initials>YN</Initials></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Nien-Chien</ForeName><Initials>NC</Initials></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Wen-Wen</ForeName><Initials>WW</Initials></Author><Author ValidYN="Y"><LastName>Kung</LastName><ForeName>Szu-Hao</ForeName><Initials>SH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Antimicrob Agents Chemother</MedlineTA><NlmUniqueID>0315061</NlmUniqueID><ISSNLinking>0066-4804</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007555">Isoxazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011760">Pyrrolidinones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>147336-22-9</RegistryNumber><NameOfSubstance UI="D049452">Green Fluorescent Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>47E5O17Y3R</RegistryNumber><NameOfSubstance UI="D010649">Phenylalanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086042">3C Viral Proteases</NameOfSubstance></Chemical><Chemical><RegistryNumber>HG18B9YRS7</RegistryNumber><NameOfSubstance UI="D014633">Valine</NameOfSubstance></Chemical><Chemical><RegistryNumber>RGE5K1Q5QW</RegistryNumber><NameOfSubstance UI="C118874">rupintrivir</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="N">3C Viral Proteases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015374" MajorTopicYN="N">Biosensing Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002459" MajorTopicYN="N">Cell Fusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D031541" MajorTopicYN="N">Fluorescence Resonance Energy Transfer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005470" MajorTopicYN="N">Fluorometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049452" MajorTopicYN="N">Green Fluorescent Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018259" MajorTopicYN="N">Herpesvirus 1, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007555" MajorTopicYN="N">Isoxazoles</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010649" MajorTopicYN="N">Phenylalanine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010957" MajorTopicYN="N">Plasmids</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011760" MajorTopicYN="N">Pyrrolidinones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014633" MajorTopicYN="N">Valine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010948" MajorTopicYN="N">Viral Plaque Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>11</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>4</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>11</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2009</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19015331</ArticleId><ArticleId IdType="pmc">PMC2630644</ArticleId><ArticleId IdType="doi">10.1128/AAC.00841-08</ArticleId><ArticleId IdType="pii">AAC.00841-08</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Barnard, D. L. 2006. Current status of anti-picornavirus therapies. Curr. Pharm. Des. 12:1379-1390.</Citation><ArticleIdList><ArticleId IdType="pubmed">16611122</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedard, K. M., and B. L. Semler. 2004. Regulation of picornavirus gene expression. Microbes Infect. 6:702-713.</Citation><ArticleIdList><ArticleId IdType="pubmed">15158778</ArticleId></ArticleIdList></Reference><Reference><Citation>Binford, S. L., F. Maldonado, M. A. Brothers, P. T. Weady, L. S. Zalman, J. W. Meador III, D. A. Matthews, and A. K. Patick. 2005. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor. Antimicrob. Agents Chemother. 49:619-626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC547258</ArticleId><ArticleId IdType="pubmed">15673742</ArticleId></ArticleIdList></Reference><Reference><Citation>Binford, S. L., P. T. Weady, F. Maldonado, M. A. Brothers, D. A. Matthews, and A. K. Patick. 2007. In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease. Antimicrob. Agents Chemother. 51:4366-4373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2167992</ArticleId><ArticleId IdType="pubmed">17908951</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair, W. S., and B. L. Semler. 1991. Role for the P4 amino acid residue in substrate utilization by the poliovirus 3CD proteinase. J. Virol. 65:6111-6123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC250289</ArticleId><ArticleId IdType="pubmed">1656088</ArticleId></ArticleIdList></Reference><Reference><Citation>Blom, N., J. Hansen, D. Blaas, and S. Brunak. 1996. Cleavage site analysis in picornaviral polyproteins: discovering cellular targets by neural networks. Protein Sci. 5:2203-2216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2143287</ArticleId><ArticleId IdType="pubmed">8931139</ArticleId></ArticleIdList></Reference><Reference><Citation>Buenz, E. J., and C. L. Howe. 2006. Picornaviruses and cell death. Trends Microbiol. 14:28-36.</Citation><ArticleIdList><ArticleId IdType="pubmed">16337385</ArticleId></ArticleIdList></Reference><Reference><Citation>De Palma, A. M., I. Vliegen, E. De Clercq, and J. Neyts. 2008. Selective inhibitors of picornavirus replication. Med. Res. Rev. doi:10.1002/med.20125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.20125</ArticleId><ArticleId IdType="pubmed">18381747</ArticleId></ArticleIdList></Reference><Reference><Citation>Erfle, H., B. Neumann, U. Liebel, P. Rogers, M. Held, T. Walter, J. Ellenberg, and R. Pepperkok. 2007. Reverse transfection on cell arrays for high content screening microscopy. Nat. Protocols. 2:392-399.</Citation><ArticleIdList><ArticleId IdType="pubmed">17406600</ArticleId></ArticleIdList></Reference><Reference><Citation>Flynn, D. L., N. A. Abood, and B. C. Holwerda. 1997. Recent advances in antiviral research: identification of inhibitors of the herpesvirus proteases. Curr. Opin. Chem. Biol. 1:190-196.</Citation><ArticleIdList><ArticleId IdType="pubmed">9667847</ArticleId></ArticleIdList></Reference><Reference><Citation>Groarke, J. M., and D. C. Pevear. 1999. Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants. J. Infect. Dis. 179:1538-1541.</Citation><ArticleIdList><ArticleId IdType="pubmed">10228078</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu, J. T., H. C. Wang, G. W. Chen, and S. R. Shih. 2006. Antiviral drug discovery targeting to viral proteases. Curr. Pharm. Des. 12:1301-1314.</Citation><ArticleIdList><ArticleId IdType="pubmed">16611117</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu, Y.-Y., Y.-N. Liu, W. Wang, F.-J. Kao, and S.-H. Kung. 2007. In vivo dynamics of enterovirus protease revealed by fluorescence resonance emission transfer (FRET) based on a novel FRET pair. Biochem. Biophys. Res. Commun. 353:939-945.</Citation><ArticleIdList><ArticleId IdType="pubmed">17207462</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang, Y.-C., W. Chen, and M. V. Yates. 2006. Use of fluorescence resonance energy transfer for rapid detection of enteroviral infection in vivo. Appl. Environ. Microbiol. 72:3710-3715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1472337</ArticleId><ArticleId IdType="pubmed">16672521</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang, Y. C., J. J. Chu, P. L. Yang, W. Chen, and M. V. Yates. 2008. Rapid identification of inhibitors that interfere with poliovirus replication using a cell-based assay. Antivir. Res. 77:232-236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7114228</ArticleId><ArticleId IdType="pubmed">18243348</ArticleId></ArticleIdList></Reference><Reference><Citation>Jares-Erijman, E. A., and T. M. Jovin. 2006. Imaging molecular interactions in living cells by FRET microscopy. Curr. Opin. Chem. Biol. 10:409-416.</Citation><ArticleIdList><ArticleId IdType="pubmed">16949332</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser, L., C. E. Crump, and F. G. Hayden. 2000. In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses. Antivir. Res. 47:215-220.</Citation><ArticleIdList><ArticleId IdType="pubmed">10974374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuechler, E., J. Seipelt, D. D. Liebig, and W. Sommergruber. 2002. Picornavirus proteinase-mediated shutoff of host cell translation: direct cleavage of a cellular initiation factor, p. 301-311. In B. L. Semler and E. Wimmer (ed.), Molecular biology of picornaviruses. ASM Press, Washington, DC.</Citation></Reference><Reference><Citation>Kuo, R.-L., S.-H. Kung, Y.-Y. Hsu, and W.-T. Liu. 2002. Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death. J. Gen. Virol. 83:1367-1376.</Citation><ArticleIdList><ArticleId IdType="pubmed">12029152</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, M.-L., T.-A. Hsu, T.-C. Chen, S.-C. Chang, J.-C. Lee, C.-C. Chen, V. Stollar, and S.-R. Shih. 2002. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology 293:386-395.</Citation><ArticleIdList><ArticleId IdType="pubmed">11886259</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebel, U., V. Starkuviene, H. Erfle, J. C. Simpson, A. Poustka, S. Wiemann, and R. Pepperkok. 2003. A microscope-based screening platform for large-scale functional protein analysis in intact cells. FEBS Lett. 554:394-398.</Citation><ArticleIdList><ArticleId IdType="pubmed">14623100</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews, D. A., P. S. Dragovich, S. E. Webber, S. A. Fuhrman, A. K. Patick, L. S. Zalman, T. F. Hendrickson, R. A. Love, T. J. Prins, J. T. Marakovits, R. Zhou, J. Tikhe, C. E. Ford, J. W. Meador, R. A. Ferre, E. L. Brown, S. L. Binford, M. A. Brothers, D. M. DeLisle, and S. T. Worland. 1999. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc. Natl. Acad. Sci. USA 96:11000-11007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC34232</ArticleId><ArticleId IdType="pubmed">10500114</ArticleId></ArticleIdList></Reference><Reference><Citation>Muir, P., U. Kammerer, K. Korn, M. N. Mulders, T. Poyry, B. Weissbrich, R. Kandolf, G. M. Cleator, and A. M. van Loon. 1998. Molecular typing of enteroviruses: current status and future requirements. Clin. Microbiol. Rev. 11:202-227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC121380</ArticleId><ArticleId IdType="pubmed">9457433</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller-Taubenberger, A., and K. Anderson. 2007. Recent advances using green and red fluorescent protein variants. Appl. Microbiol. Biotechnol. 77:1-12.</Citation><ArticleIdList><ArticleId IdType="pubmed">17704916</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacios, G., and M. S. Oberste. 2005. Enteroviruses as agents of emerging infectious diseases. J. Neurovirol. 11:424-433.</Citation><ArticleIdList><ArticleId IdType="pubmed">16287683</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallai, P. V., F. Burkhardt, M. Skoog, K. Schreiner, P. Bax, K. A. Cohen, G. Hansen, D. E. Palladino, K. S. Harris, and M. J. Nicklin. 1989. Cleavage of synthetic peptides by purified poliovirus 3C proteinase. J. Biol. Chem. 264:9738-9741.</Citation><ArticleIdList><ArticleId IdType="pubmed">2542331</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallansch, M., and R. Roos. 2007. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, p. 839-893. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed. Lippincott Williams &amp; Wilkins, Philadelphia, PA.</Citation></Reference><Reference><Citation>Patick, A. K., S. L. Binford, M. A. Brothers, R. L. Jackson, C. E. Ford, M. D. Diem, F. Maldonado, P. S. Dragovich, R. Zhou, T. J. Prins, S. A. Fuhrman, J. W. Meador, L. S. Zalman, D. A. Matthews, and S. T. Worland. 1999. In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrob. Agents Chemother. 43:2444-2450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC89498</ArticleId><ArticleId IdType="pubmed">10508022</ArticleId></ArticleIdList></Reference><Reference><Citation>Patick, A. K., and K. E. Potts. 1998. Protease inhibitors as antiviral agents. Clin. Microbiol. Rev. 11:614-627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC88900</ArticleId><ArticleId IdType="pubmed">9767059</ArticleId></ArticleIdList></Reference><Reference><Citation>Piston, D. W., and G.-J. Kremers. 2007. Fluorescent protein FRET: the good, the bad and the ugly. Trends Biochem. Sci. 32:407-414.</Citation><ArticleIdList><ArticleId IdType="pubmed">17764955</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidtke, M., E. Hammerschmidt, S. Schuler, R. Zell, E. Birch-Hirschfeld, V. A. Makarov, O. B. Riabova, and P. Wutzler. 2005. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment. J. Antimicrob. Chemother. 56:648-656.</Citation><ArticleIdList><ArticleId IdType="pubmed">16150864</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih, S.-R., S.-J. Chen, G. H. Hakimelahi, H.-J. Liu, C.-T. Tseng, and K.-S. Shia. 2004. Selective human enterovirus and rhinovirus inhibitors: an overview of capsid-binding and protease-inhibiting molecules. Med. Res. Rev. 24:449-474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7168432</ArticleId><ArticleId IdType="pubmed">15170592</ArticleId></ArticleIdList></Reference><Reference><Citation>Tawa, P., J. Tam, R. Cassady, D. W. Nicholson, and S. Xanthoudakis. 2001. Quantitative analysis of fluorescent caspase substrate cleavage in intact cells and identification of novel inhibitors of apoptosis. Cell Death Differ. 8:30-37.</Citation><ArticleIdList><ArticleId IdType="pubmed">11313700</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Q. M., and S. H. Chen. 2007. Human rhinovirus 3C protease as a potential target for the development of antiviral agents. Curr. Protein Pept. Sci. 8:19-27.</Citation><ArticleIdList><ArticleId IdType="pubmed">17305557</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, J., Z. Zhang, J. Lin, J. Lu, B.-F. Liu, S. Zeng, and Q. Luo. 2007. Detection of MMP activity in living cells by a genetically encoded surface-displayed FRET sensor. Biochim. Biophys. Acta 1773:400-407.</Citation><ArticleIdList><ArticleId IdType="pubmed">17187878</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>